Very proud to share scROSHI, a cell type annotation method developed for single cell by the Nexus team with whom I collaborated. If you need to annotate single-cells, look no further! biorxiv.org/content/10.110…

Very excited to share our new paper, now out in Science Translational Medicine! science.org/doi/10.1126/sc… (1/3)

Proud and honoured to see our team effort published in Cell Reports. Special thx to @mailaved and Wilhelm Sander-Stiftung #glycotime Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways cell.com/cell-reports/f…

Exciting science being presented and discussed at this year‘s Department of Biomedicine Summer Symposium. Hope to see you all there on Wednesday! UniSpitalBaselCH Universität Basel biomedizin.unibas.ch/en/seminars/de…

Registration now open for Glycobasque 5 18-19 November 2022, San Sebastian, Spain keynotes: Henrik Clausen, DK Geert-Jan Boons, NL, USA M.G. Finn, USA Sabine Flitsch, UK details: glycobasque.es

If you are a scientist interested in glycobiology and cancer immunotherapy, please apply! jobs.unibas.ch/offene-stellen…

Recent review together with Daniel Maslyar and Sam Nalle on Siglecs and sialic acids as target for cancer immunotherapy #glycotime #Immunotherapy Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches aacrjournals.org/cancerimmunolr…

CRISPR-Cas9 approach for assessing genes predicting PARP inhibition published in CDD press, nature.com/articles/s4141… Great team effort! Special thanks to Ricardo Coelho, Department of Biomedicine and UniSpitalBaselCH

Making glycosylation "hot" for cancer immunotherapy: wonderful collaboration with Heinz Läubli Heinz Läubli at Department of Biomedicine and UniSpitalBaselCH science.org/doi/10.1126/sc… Much appreciated, thanks !

Cancer cells use sugar molecules on their surface to disable attacks by the body’s immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized. Heinz Läubli Department of Biomedicine UniSpitalBaselCH unibas.ch/en/News-Events…

Join our team!! Xmas came early in the form of a grant 😁 We are looking to fill TWO postdoc positions in chemoenzymatic and/or carbohydrate synthesis, with a focus on developing new glycan-based antimicrobial therapies. #GlycoTime #ChemPostdoc More info in thread 👇👇👇

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing for personalized oncology biorxiv.org/cgi/content/sh… #bioRxiv

One week left to submit an application for our open 🌟 glycochemistry postdoc 🌟 positions! Interested candidates can apply via the UniBasel job portal link in the thread below #GlycoTime European Glycoscience Community INNOGLY COST Action ACS_CARB Glyco@Alps GlycoNet GFRGlyco GlycoPM The NCFG

Pleased to share our review discussing the future of #prostatecancer patient-derived #xenografts published in Nature Reviews Urology . Great effort tackling this topic from Mitchell Lawrence, Renea Taylor, and Gail Risbridger: nature.com/articles/s4158…

Do not forget the deadline for #ESUR23 🔔! Looking forward to receiving your #UrologicalResearch abstracts and to welcoming you in Basel 🧫 🧬🔬

Exciting time! Long-read scRNAseq unveils novel insights into ovarian cancer metastasis. We detected 52,000+ previously unreported isoforms, identified cell-specific changes, gene fusions, & confirmed mutations. nature.com/articles/s4146… #Genomics #ovariancancer

Delighted to present our full-length scRNA-seq study on ovarian cancer patients, in collaboration with the University Hospital Basel Francis Jacob ! nature.com/articles/s4146… Can we simultaneously detect isoform-level gene expression, mutations and gene fusions in cancer cells? 1/

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis biorxiv.org/cgi/content/sh… #biorxiv_cancer

Exciting news! The 7th issue of our DBM newsletter is here! We hope you enjoy reading it! 👇🏼👇🏼👇🏼 issuu.com/departementbio… #Newsletter #DBMBasel #departmentofbiomedicine #science #research #biomedicine

📢 Exciting #PhD Opportunity in Carbohydrate Chemistry! Join our team Universität Basel to drive developments in glycan-based therapies 💊 🗓️Feb 2025 📍Switzerland 💼4-year funded 🔗Link below #GlycoTime #AcademicJobs European Glycoscience Community Australian Glycoscience Society GlycoNet ACS_CARB EuChemS Glyco@Alps